Dr Moataaz will highlight the role of advanced molecular modeling techniques
and modern structure prediction tools in improving our understanding of drug targets
He will also discuss how generative artificial intelligence is enabling the design of new molecules and helping optimize multiple drug properties at the same time. In addition, the lecture will address how early prediction of drug safety and toxicity can reduce risks and lower the cost of drug development.